Journey Medical (NASDAQ:DERM) reported its Q1 earnings results on Monday, May 22, 2023 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Journey Medical beat estimated earnings by 33.33%, reporting an EPS of $-0.3 versus an estimate of $-0.45.
Revenue was down $11.08 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.3 which was followed by a 10.34% increase in the share price the next day.
Here’s a look at Journey Medical’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.47 | -0.40 | -0.26 | -0.31 |
| EPS Actual | -0.17 | -0.23 | -0.15 | 0.11 |
| Revenue Estimate | 16.58M | 17.65M | 21.31M | 22.15M |
| Revenue Actual | 15.97M | 16.12M | 18.29M | 23.30M |
To track all earnings releases for Journey Medical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
